Weed-Derived Secondary Metabolites in Polycystic Ovary Syndrome: Target Engagement, Exposure Plausibility and a Safety-Gated Framework for Candidate Prioritization

Background/Objectives: Existing PCOS reviews largely catalogue natural products and reported molecular pathways. This structured critical review asks a different translational question: which constituents from weed, ruderal and invasive taxa remain credible candidates when target engagement, pharmacological direction, realistic exposure and safety are considered together. Methods: PubMed/MEDLINE, Web of Science Core Collection and CAB Abstracts were searched from inception to 2 September 2026, with CABI resources used to verify weed status. Eligible pharmacological, pharmacokinetic and toxicological evidence was critically appraised using a T1–T4 mechanistic evidence hierarchy and evaluated for exposure plausibility, methodological quality and citation integrity. Results: No positive mechanistic claim reached T3 or T4. Urtica dioica L. lignans demonstrably displace dihydrotestosterone from SHBG in vitro, but the predicted consequence for free androgen exposure in vivo remains untested; flavonoid aromatase effects are assay- and context-dependent; and several widely cited systemic mechanisms are not supported by current exposure data. Silybin exposure supports a narrower liver-directed hypothesis, whereas non-absorbed inulin-type fructans provide a luminal gut-axis case in which systemic exposure is not required. Mentha spicata L. provides a reproducible human endocrine signal but no defined active constituent or molecular target. Conclusions: The principal barrier to clinical translation is not a shortage of activity signals but the absence of demonstrated in vivo target engagement, target-site pharmacokinetics and reproductive-safety qualification. No candidate currently clears all five gates. Silybum marianum flavonolignans and Cichorium intybus inulin-type fructans are therefore only provisionally prioritized for node-specific nonclinical development, while M. spicata is a mechanism-resolution research signal rather than a pharmacological lead. The framework prioritizes the experiments needed to establish development readiness; it does not infer PCOS-specific efficacy from the existing evidence.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-11-16
DOI
https://doi.org/10.3390/ph19111816
Primary Topic
Ovarian function and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Weed-Derived Secondary Metabolites in Polycystic Ovary Syndrome: Target Engagement, Exposure Plausibility and a Safety-Gated Framework for Candidate Prioritization

Pallav Sengupta, Priyanshu Priya, Sulagna Dutta, Amit Mittal et al.
4 links
Pharmaceuticals
Ovarian function and disorders
article

Weed-Derived Secondary Metabolites in Polycystic Ovary Syndrome: Target Engagement, Exposure Plausibility and a Safety-Gated Framework for Candidate Prioritization

Pallav Sengupta, Priyanshu Priya, Sulagna Dutta, Amit Mittal, Motamarri V. N. L. Chaitanya
article en

Abstract

Background/Objectives: Existing PCOS reviews largely catalogue natural products and reported molecular pathways. This structured critical review asks a different translational question: which constituents from weed, ruderal and invasive taxa remain credible candidates when target engagement, pharmacological direction, realistic exposure and safety are considered together. Methods: PubMed/MEDLINE, Web of Science Core Collection and CAB Abstracts were searched from inception to 2 September 2026, with CABI resources used to verify weed status. Eligible pharmacological, pharmacokinetic and toxicological evidence was critically appraised using a T1–T4 mechanistic evidence hierarchy and evaluated for exposure plausibility, methodological quality and citation integrity. Results: No positive mechanistic claim reached T3 or T4. Urtica dioica L. lignans demonstrably displace dihydrotestosterone from SHBG in vitro, but the predicted consequence for free androgen exposure in vivo remains untested; flavonoid aromatase effects are assay- and context-dependent; and several widely cited systemic mechanisms are not supported by current exposure data. Silybin exposure supports a narrower liver-directed hypothesis, whereas non-absorbed inulin-type fructans provide a luminal gut-axis case in which systemic exposure is not required. Mentha spicata L. provides a reproducible human endocrine signal but no defined active constituent or molecular target. Conclusions: The principal barrier to clinical translation is not a shortage of activity signals but the absence of demonstrated in vivo target engagement, target-site pharmacokinetics and reproductive-safety qualification. No candidate currently clears all five gates. Silybum marianum flavonolignans and Cichorium intybus inulin-type fructans are therefore only provisionally prioritized for node-specific nonclinical development, while M. spicata is a mechanism-resolution research signal rather than a pharmacological lead. The framework prioritizes the experiments needed to establish development readiness; it does not infer PCOS-specific efficacy from the existing evidence.

PharmaceuticalsVol. 19(11)
Lovely Professional University (IN), Gulf Medical University (AE), Ajman University (AE)
Good health and well-being
Ovarian function and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon